BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20123861)

  • 1. Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus.
    Crowther-Swanepoel D; Broderick P; Ma Y; Robertson L; Pittman AM; Price A; Twiss P; Vijayakrishnan J; Qureshi M; Dyer MJ; Matutes E; Dearden C; Catovsky D; Houlston RS
    Hum Mol Genet; 2010 May; 19(9):1840-5. PubMed ID: 20123861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.
    Slager SL; Achenbach SJ; Asmann YW; Camp NJ; Rabe KG; Goldin LR; Call TG; Shanafelt TD; Kay NE; Cunningham JM; Wang AH; Weinberg JB; Norman AD; Link BK; Leis JF; Vachon CM; Lanasa MC; Caporaso NE; Novak AJ; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):461-6. PubMed ID: 23307532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.
    Slager SL; Rabe KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Lanasa MC; Spector LG; Rassenti LZ; Leis JF; Camp NJ; Glenn M; Kay NE; Cunningham JM; Hanson CA; Marti GE; Weinberg JB; Morrison VA; Link BK; Call TG; Caporaso NE; Cerhan JR
    Blood; 2011 Feb; 117(6):1911-6. PubMed ID: 21131588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk.
    Crowther-Swanepoel D; Mansouri M; Enjuanes A; Vega A; Smedby KE; Ruiz-Ponte C; Jurlander J; Juliusson G; Montserrat E; Catovsky D; Campo E; Carracedo A; Rosenquist R; Houlston RS
    Br J Haematol; 2010 Aug; 150(4):473-9. PubMed ID: 20553269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine scale mapping of the breast cancer 16q12 locus.
    Udler MS; Ahmed S; Healey CS; Meyer K; Struewing J; Maranian M; Kwon EM; Zhang J; Tyrer J; Karlins E; Platte R; Kalmyrzaev B; Dicks E; Field H; Maia AT; Prathalingam R; Teschendorff A; McArthur S; Doody DR; Luben R; Caldas C; Bernstein L; Kolonel LK; Henderson BE; Wu AH; Le Marchand L; Ursin G; Press MF; Lindblom A; Margolin S; Shen CY; Yang SL; Hsiung CN; Kang D; Yoo KY; Noh DY; Ahn SH; Malone KE; Haiman CA; Pharoah PD; Ponder BA; Ostrander EA; Easton DF; Dunning AM
    Hum Mol Genet; 2010 Jun; 19(12):2507-15. PubMed ID: 20332101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong.
    Lan Q; Au WY; Chanock S; Tse J; Wong KF; Shen M; Siu LP; Yuenger J; Yeager M; Hosgood HD; Purdue MP; Liang R; Rothman N
    Eur J Haematol; 2010 Dec; 85(6):492-5. PubMed ID: 20731705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 46 novel SNPs in the 130-kb region containing a myocardial infarction susceptibility gene on chromosomal band 6p21.
    Iida A; Ozaki K; Ohnishi Y; Tanaka T; Nakamura Y
    J Hum Genet; 2003; 48(9):476-479. PubMed ID: 12920609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF4 mutations in chronic lymphocytic leukemia.
    Havelange V; Pekarsky Y; Nakamura T; Palamarchuk A; Alder H; Rassenti L; Kipps T; Croce CM
    Blood; 2011 Sep; 118(10):2827-9. PubMed ID: 21791429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.
    Ma S; Shukla V; Fang L; Gould KA; Joshi SS; Lu R
    J Biol Chem; 2013 Sep; 288(37):26430-40. PubMed ID: 23897826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy.
    Li M; Wang L; Shi DC; Foo JN; Zhong Z; Khor CC; Lanzani C; Citterio L; Salvi E; Yin PR; Bei JX; Wang L; Liao YH; Chen J; Chen QK; Xu G; Jiang GR; Wan JX; Chen MH; Chen N; Zhang H; Zeng YX; Liu ZH; Liu JJ; Yu XQ
    J Am Soc Nephrol; 2020 Dec; 31(12):2949-2963. PubMed ID: 32912934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility variants for chronic lymphocytic leukemia.
    Slager SL; Goldin LR; Strom SS; Lanasa MC; Spector LG; Rassenti L; Leis JF; Camp NJ; Kay NE; Vachon CM; Glenn M; Weinberg JB; Rabe KG; Cunningham JM; Achenbach SJ; Hanson CA; Marti GE; Call TG; Caporaso NE; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1098-102. PubMed ID: 20332261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma.
    Pratt G; Fenton JA; Allsup D; Fegan C; Morgan GJ; Jackson G; Sunter NJ; Hall AG; Irving JA; Allan JM
    Br J Haematol; 2010 Aug; 150(3):371-3. PubMed ID: 20408839
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia.
    Sillé FC; Thomas R; Smith MT; Conde L; Skibola CF
    PLoS One; 2012; 7(1):e29632. PubMed ID: 22235315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.
    Di Bernardo MC; Crowther-Swanepoel D; Broderick P; Webb E; Sellick G; Wild R; Sullivan K; Vijayakrishnan J; Wang Y; Pittman AM; Sunter NJ; Hall AG; Dyer MJ; Matutes E; Dearden C; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Hillmen P; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Allan JM; Catovsky D; Houlston RS
    Nat Genet; 2008 Oct; 40(10):1204-10. PubMed ID: 18758461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element.
    Clop A; Bertoni A; Spain SL; Simpson MA; Pullabhatla V; Tonda R; Hundhausen C; Di Meglio P; De Jong P; Hayday AC; Nestle FO; Barker JN; Bell RJ; Capon F; Trembath RC
    PLoS One; 2013; 8(8):e71690. PubMed ID: 23990973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection.
    Tao J; Su K; Yu C; Liu X; Wu W; Xu W; Jiang B; Luo R; Yao J; Zhou J; Zhan Y; Ye C; Yuan W; Jiang X; Cui W; Li MD; Li L
    Amino Acids; 2015 Dec; 47(12):2623-34. PubMed ID: 26197724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic expression imbalance screening of genes in chromosome 1q21-24 region to identify functional variants for Type 2 diabetes susceptibility.
    Mondal AK; Sharma NK; Elbein SC; Das SK
    Physiol Genomics; 2013 Jul; 45(13):509-20. PubMed ID: 23673729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.
    Slager SL; Camp NJ; Conde L; Shanafelt TD; Achenbach SJ; Rabe KG; Kay NE; Novak AJ; Call TG; Bracci PM; Sille FM; Sanchez S; Akers NK; Cunningham JM; Serie DJ; McDonnell SK; Leis JF; Wang AH; Weinberg JB; Glenn M; Link B; Vachon CM; Lanasa MC; Skibola CF; Cerhan JR
    Br J Haematol; 2012 Dec; 159(5):572-6. PubMed ID: 23025533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.
    Berndt SI; Camp NJ; Skibola CF; Vijai J; Wang Z; Gu J; Nieters A; Kelly RS; Smedby KE; Monnereau A; Cozen W; Cox A; Wang SS; Lan Q; Teras LR; Machado M; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Vajdic CM; Cocco P; Zhang Y; Giles GG; Zeleniuch-Jacquotte A; Lawrence C; Montalvan R; Burdett L; Hutchinson A; Ye Y; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Cunningham JM; Allmer C; Hjalgrim H; Adami HO; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Arnett DK; Zhi D; Leach JM; Holly EA; Jackson RD; Tinker LF; Benavente Y; Sala N; Casabonne D; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Chaffee KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Leis JF; Weinberg JB; Caporaso NE; Norman AD; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Masala G; Weiderpass E; Chirlaque MD; Vermeulen RCH; Travis RC; Southey MC; Milne RL; Albanes D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Villano DJ; Maria A; Spinelli JJ; Gascoyne RD; Connors JM; Bertrand KA; Giovannucci E; Kraft P; Kricker A; Turner J; Ennas MG; Ferri GM; Miligi L; Liang L; Ma B; Huang J; Crouch S; Park JH; Chatterjee N; North KE; Snowden JA; Wright J; Fraumeni JF; Offit K; Wu X; de Sanjose S; Cerhan JR; Chanock SJ; Rothman N; Slager SL
    Nat Commun; 2016 Mar; 7():10933. PubMed ID: 26956414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.